Cite
HARVARD Citation
Lin, E. et al. (2019). Safety and outcomes of 177Lu‐DOTATATE for neuroendocrine tumours: experience in New South Wales, Australia. Internal medicine journal. 49 (10), pp. 1268-1277. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lin, E. et al. (2019). Safety and outcomes of 177Lu‐DOTATATE for neuroendocrine tumours: experience in New South Wales, Australia. Internal medicine journal. 49 (10), pp. 1268-1277. [Online].